Earnings calendar/MREO
Mereo BioPharma Group plc (MREO)
Next report date and post-earnings actuals — standardized metrics from the filed statements. No analyst estimates, no narrative, no price targets.
Pre-earnings
The next report date (from the company's filing cadence) and how the business has been running.
Latest EPS YoY
+50.0%
vs 2025-08-12
Latest revenue YoY
-100.0%
How results look so far
Trailing revenue (avg 4Q)
$150,000
Printed quarters
EPS beat rate (4Q)
50%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 11, 2026
EPS beat
EPS actual / est
$-0.01 / $-0.01
0.0%
Revenue actual / est
$0 / $3.5M
-100.0%
Result
Target reached
EPS vs prior estimate, when one exists
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 8/11/2026 | $-0.01 | $-0.01 | 0.0% | $3.5M | $0 | -100.0% |
| 5/12/2026 | $0.02 | $-0.01 | -150.0% | $11.7M | Pending | — |
| 3/25/2026upcoming | $-0.01 | Pending | — | $5.3M | Pending | — |
| 3/19/2026 | $-0.01 | $-0.01 | 0.0% | $23.3M | Pending | — |
| 11/10/2025 | $-0.01 | $-0.01 | -20.5% | $5.3M | $300,000 | -94.3% |
| 8/12/2025 | $-0.01 | $-0.02 | -100.0% | — | $685,710 | — |
| 5/13/2025 | $-0.01 | $-0.02 | -100.0% | $11.9M | Pending | — |
| 3/26/2025 | $-0.02 | $-0.01 | +50.0% | $11.9M | $1.3M | -88.8% |
| 11/12/2024 | $-1.36 | $-7.69 | -465.4% | — | Pending | — |
| 8/13/2024 | $-0.78 | $-0.02 | +97.4% | — | Pending | — |
| 5/15/2024 | — | $-0.01 | — | — | Pending | — |
| 3/27/2024 | $-0.02 | $-0.01 | +44.5% | — | $456,430.92 | — |
| 11/17/2023 | — | $-0.01 | — | — | $648,810.58 | — |
| 9/7/2023 | $-0.02 | $-0.03 | -37.0% | — | $11.1M | — |
| 6/27/2023 | — | $-0.01 | — | — | $4.4M | — |
| 3/28/2023 | $-0.05 | $-0.03 | +28.8% | — | $1.0M | — |
| 11/2/2022 | $-0.38 | $-0.02 | +95.6% | — | $746,785.76 | — |
| 6/30/2022 | — | $-0.05 | — | — | Pending | — |
| 4/1/2022 | $-4.50 | $0.00 | +100.0% | — | Pending | — |
| 3/31/2022 | — | $-0.03 | — | — | $606,456.08 | — |
Need MREO data in your own agent or pipeline?
The earnings data on this page — report dates, filed EPS/revenue actuals and run-rate history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.